AGÕæÈ˹ٷ½

STOCK TITAN

Equifax Inc SEC Filings

EFX NYSE

Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Equifax’s credit files touch nearly every U.S. consumer, and that reach makes its SEC disclosures uniquely data-dense. The annual 10-K doesn’t just report revenue; it details cybersecurity investments, Equifax Cloud migration milestones, and how Workforce Solutions monetizes real-time income data. Whether you’re tracking credit-report volume, breach-related legal accruals, or global segment trends, this page gathers every document in one place and keeps it current.

Looking for the Equifax annual report 10-K simplified, the latest Equifax quarterly earnings report 10-Q filing, or an Equifax 8-K material events explained alert? They’re here alongside Equifax proxy statement executive compensation materials and each Equifax insider trading Form 4 transactions notice. Stock Titan’s AI reads the footnotes so you don’t have to, producing plain-English briefs that answer natural queries like “What are Equifax’s cyber spend trends?� or “How did Workforce Solutions margin move this quarter?� Our platform also streams Equifax Form 4 insider transactions real-time, highlighting officer buys and sells minutes after they hit EDGAR.

Use the summaries to compare fraud-loss reserves between periods, spot patterns in Equifax executive stock transactions Form 4, or dive into our Equifax earnings report filing analysis for revenue-per-file metrics. From risk factors to segment tables, you’ll find Equifax SEC filings explained simply; it’s all about understanding Equifax SEC documents with AI—faster, clearer, and always up to date.

Rhea-AI Summary

Equifax insider sale by EVP/CFO/COO. John W. Gamble Jr., Equifax (EFX) executive, sold 3,000 shares of Common Stock on 08/18/2025 at $247.35 per share under a pre-established Rule 10b5-1 trading plan adopted 05/14/2025. After the sale he beneficially owns 62,202 shares, which figure includes accrued dividend equivalent units reinvested into restricted stock units through the company’s last dividend payment date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/20/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Equifax, Incorporated (EFX) filing a Form 144 notifies a proposed sale of 8,797 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $2,199,425.95. The filing shows the shares to be sold on 08/20/2025. The shares were acquired by option with grant date 05/01/2023 and the acquisition/expected sale date listed as 08/20/2025, with payment in cash. Total shares outstanding reported are 123,797,380. The filer certifies no undisclosed material adverse information and provides standard Rule 144 representations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Equifax (EFX) Form 144 notice reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services with an aggregate market value of $742,050. The shares represent restricted stock that vested and were acquired on 02/23/2024 as compensation from the issuer. The filing shows 123,797,380 shares outstanding and lists an approximate sale date of 08/18/2025 on the NYSE. The filer states there were no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
insider
-
Filing
Rhea-AI Summary

Equifax Inc. (EFX) Form 144 filing: CEO Mark W. Begor has filed notice to sell up to 48,264 common shares through Fidelity Brokerage on or after 07/28/2025. At the last reported market price, the proposed sale is valued at $11.85 million. The filing lists 123,797,380 shares outstanding, so the planned disposition equals roughly 0.04 % of total shares.

The shares come from two prior equity awards:

  • 20,304 shares vested as restricted stock on 05/04/2021 (non-cash compensation).
  • 27,960 shares from options granted 02/21/2020 and exercised for cash on 07/28/2025.
Rule 144 also discloses that Begor previously sold 22,160 shares on 04/28/2025 for $5.69 million.

No additional financial metrics, earnings data, or company guidance are included in this short-form notice; the document solely satisfies SEC requirements for advance disclosure of certain insider sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.6%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.18%
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.18%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Equifax (EFX)?

The current stock price of Equifax (EFX) is $248.35 as of August 20, 2025.

What is the market cap of Equifax (EFX)?

The market cap of Equifax (EFX) is approximately 30.3B.
Equifax Inc

NYSE:EFX

EFX Rankings

EFX Stock Data

30.26B
123.10M
0.52%
98.02%
2.29%
Consulting Services
Services-consumer Credit Reporting, Collection Agencies
United States
ATLANTA